Marzena Gajęcka

Prof. Marzena Gajęcka

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2007 in American Journal of Medical Genetics Part C: Seminars in Medical Genetics
Verified
Journal Article
Closed access
PDF file
MGMarzena Gajęcka
Marzena Gajęcka
KMKatherine L. Mackay
Katherine L. Mackay
LSLisa G. Shaffer
Lisa G. Shaffer

5 June 2008 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
WDWilliam B. Dobyns
William B. Dobyns
GMGhayda Mirzaa
Ghayda Mirzaa
SCSusan L. Christian
Susan L. Christian
KPKristin Petras
Kristin Petras
JRJessica Roseberry
Jessica Roseberry
LSLisa G. Shaffer
Lisa G. Shaffer

19 October 2015 in Molecular Genetics and Genomics
Verified
Journal Article
Open access
PDF file
MGMarzena Gajęcka
Marzena Gajęcka
Mosaicism refers to the presence in an individual of normal and abnormal cells that are genotypically distinct and are derived from a single zygote. The incidence of mosaicism events in the human body is underestimated as the genotypes in the mosaic ratio, especially in the low-grade mosaicism, stay unrevealed. This review summarizes various research outcomes and diagnostic questions in relation to different types of mosaicism. The impact of both tested biological material and applied method on the mosaicism detection rate is especially highlighted. As next-generation sequencing technologies constitute a promising methodological solution in mosaicism detection in the coming years, revisions in current diagnostic protocols are necessary to increase the detection rate of the unrevealed mosaicism events. Since mosaicism identification is a complex process, numerous examples of multistep mosaicism investigations are presented and discussed.

1 February 2017 in European Journal of Human Genetics
Verified
Journal Article
Closed access
MKMichal Kabza
Michal Kabza
JKJustyna Karolak
Justyna Karolak
MRMalgorzata Rydzanicz
Malgorzata Rydzanicz
MSMichał Szcześniak
Michał Szcześniak
DNDorota M. Nowak-Malczewska
Dorota M. Nowak-Malczewska
MGMarzena Gajęcka
Marzena Gajęcka

1 September 2017 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
JKJoanna Kurczewska
Joanna Kurczewska
PPPaulina Pecyna
Paulina Pecyna
MRMagdalena Ratajczak
Magdalena Ratajczak
MGMarzena Gajęcka
Marzena Gajęcka
GSGrzegorz Schroeder
Grzegorz Schroeder
The influence of an inorganic support - halloysite nanotubes - on the release rate and biological activity of the antibiotic encapsulated in alginate-based dressings was studied. The halloysite samples were loaded with approx. 10 wt.% of the antibiotic and then encapsulated in Alginate and Gelatin/Alginate gels. The material functionalized with aliphatic amine significantly extended the release of vancomycin from alginate-based gels as compared to that achieved when silica was used. After 24 h, the released amounts of the antibiotic immobilized at silica reached 70%, while for the drug immobilized at halloysite the released amount of vancomycin reached 44% for Alginate discs. The addition of gelatin resulted in even more prolonged sustained release of the drug. The antibiotic was released from the system with a double barrier with Higuchi kinetic model and Fickian diffusion mechanism. Only the immobilized drug encapsulated in Alginate gel demonstrated very good antimicrobial activity against various bacteria. The inhibition zones were greater than those of the standard discs for the staphylococci and enterococci bacteria tested. The addition of gelatin adversely affected the biological activity of the system. The inhibition zones were smaller than those of the reference samples. A reduction in the drug dose by half had no significant effect on changing the release rate and microbiological activity. The in vivo toxicity studies of the material with immobilized drug were carried out with Acutodesmus acuminatus and Daphnia magna. The material studied had no effect on the living organisms used in the bioassays. The proposed system with a double barrier demonstrated high storage stability.

24 November 2010 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
MGMarzena Gajęcka
Marzena Gajęcka
SSSulagna C. Saitta
Sulagna C. Saitta
AGAndrew J. Gentles
Andrew J. Gentles
LCLindsey Campbell
Lindsey Campbell
KCKaren Ciprero
Karen Ciprero
LSLisa G. Shaffer
Lisa G. Shaffer